Paul E. Gottschall

University of Arkansas, USA

Articles in Scholarly Journals [Incomplete List]

  1. Versican and brevican are expressed with distinct pathology in neonatal hypoxic-ischemic injury
    Journal of Neuroscience Research, vol. 86, no. 5, pp. 1106–1114, 2008
  2. Deglycosylated Anti-Aβ Antibody Dose–Response Effects on Pathology and Memory in APP Transgenic Mice
    Journal of Neuroimmune Pharmacology, vol. 3, no. 3, pp. 187–197, 2008
  3. Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice
    Molecular Therapy, vol. 16, no. 9, Article ID mt2008148, 6 pages, 2008
  4. Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain
    BMC Neuroscience, vol. 9, no. 1, p. 14, 2008
  5. Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat
    Journal of Neuroinflammation, vol. 5, no. 1, p. 34, 2008
  6. Pre-assembled clusters distort crystal nucleation kinetics in supersaturated lysozyme solutions
    Biophysical Chemistry, vol. 129, no. 2-3, pp. 224–234, 2007
  7. Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension
    Experimental Neurology, 2007
  8. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma
    Brain Cell Biology, vol. 35, no. 2-3, pp. 159–172, 2007
  9. Deglycosylated Anti-Amyloid-beta Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice
    Journal of Neuroscience, vol. 26, no. 20, pp. 5340–5346, 2006
  10. Journal of Neuroinflammation, vol. 3, no. 1, p. 11, 2006
  11. BMC Neuroscience, vol. 6, no. 1, p. 52, 2005
  12. Altered production and proteolytic processing of brevican by transforming growth factor beta in cultured astrocytes
    Journal of Neurochemistry, vol. 93, no. 6, pp. 1533–1541, 2005
  13. The effect of hypoxic?ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2
    Experimental Neurology, vol. 193, no. 1, pp. 149–162, 2005
  14. Biochemical Journal, vol. 377, no. 3, p. 787, 2004
  15. β-Amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes
    Brain Research, vol. 970, no. 1-2, pp. 205–213, 2003
  16. Activation of the Proteolytic Activity of ADAMTS4 (Aggrecanase-1) by C-terminal Truncation
    Journal of Biological Chemistry, vol. 277, no. 13, pp. 11034–11041, 2002
  17. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats
    Neuroscience, 2002
  18. Role and Mechanisms of Interleukin-1 in the Modulation of Neurotoxicity
    Neuroimmunomodulation, vol. 10, no. 4, pp. 199–207, 2002
  19. Number of A Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque Levels
    DNA and Cell Biology, vol. 20, no. 11, pp. 731–736, 2001
  20. Nature, vol. 408, no. 6815, pp. 982–985, 2000
  21. Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid
    Neuroscience Letters, vol. 295, no. 1-2, pp. 9–12, 2000
  22. Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to ?-amyloid peptide
    Journal of Neuroscience Research, vol. 55, no. 1, pp. 44–53, 1999
  23. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification
    Journal of Neuroscience Methods, vol. 76, no. 1, pp. 15–20, 1997
  24. Effects of phenobarbital and interleukin-6 on cytochrome P4502B1 and 2B2 in cultured rat hepatocytes
    Biochemical Pharmacology, vol. 51, no. 5, pp. 701–706, 1996
  25. Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and Neurons
    Neuroimmunomodulation, vol. 3, no. 2-3, pp. 69–75, 1996
  26. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture
    Journal of Neuroscience Research, vol. 42, no. 3, pp. 335–342, 1995
  27. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes
    Biochemical Pharmacology, vol. 49, no. 1, pp. 97–104, 1995
  28. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP)
    Brain Research, vol. 637, no. 1-2, pp. 197–203, 1994
  29. Rapid Increase in Plasma IL-6 after Hemorrhage, and Posthemorrhage Reduction of the IL-6 Response to LPS<sub>f</sub>in Conscious Rats: Interrelation with Plasma Corticosterone Levels
    Neuroimmunomodulation, vol. 1, no. 2, pp. 127–134, 1994
  30. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands
    Peptides, vol. 14, no. 1, pp. 59–65, 1993
  31. Increased sensitivity of glioblastoma cells to interleukin 1 after long-term incubation with dexamethasone
    Molecular and Cellular Neuroscience, vol. 3, no. 1, pp. 49–55, 1992
  32. Increased Circulating Interleukin-1 and Interleukin-6 after Intracerebroventricular Injection of Lipopolysaccharide
    Neuroendocrinology, vol. 56, no. 6, pp. 935–938, 1992
  33. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: Molecular identification and interaction with vasoactive intestinal peptide (VIP)
    Peptides, vol. 12, no. 3, pp. 617–621, 1991
  34. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes
    Biochemical and Biophysical Research Communications, vol. 168, no. 3, pp. 1027–1033, 1990
  35. Molecular identification of receptor for pituitary adenylate cyclase activating polypeptide
    Biochemical and Biophysical Research Communications, vol. 171, no. 2, pp. 838–844, 1990
  36. Interleukin-1 beta is more potent than interleukin-1 alpha in supressing follicle-stimulating hormone-induced differentiation of ovarian granulosa cells
    Biochemical and Biophysical Research Communications, vol. 163, no. 2, pp. 764–770, 1989
  37. Interleukin-1 suppresses follicle-stimulating hormone-induced estradiol secretion from cultured ovarian granulosa cells
    Journal of Reproductive Immunology, vol. 15, no. 3, pp. 281–290, 1989
  38. Gonadotropin-releasing hormone binding sites in ovaries of normal cycling and persistent-estrus rats
    Biology of Reproduction, vol. 41, no. 3, pp. 505–511, 1989
  39. Discordance in the effects of interleukin-1 on rat granulosa cell differentiation induced by follicle-stimulating hormone or activators of adenylate cyclase
    Biology of Reproduction, vol. 39, no. 5, pp. 1074–1085, 1988
  40. Identification of a high-affinity receptor for interleukin-1 beta in rat brain
    Biochemical and Biophysical Research Communications, vol. 156, no. 1, pp. 61–67, 1988
  41. Differential Activity of Thymosin Peptides (Thymosin Fraction 5) on Plasma Thyrotropin in Female Rats of Different Ages
    Neuroendocrinology, vol. 47, no. 5, pp. 379–383, 1988
  42. Growth Hormone Secretory Patterns in Young, Middle-Aged and Old Female Rats
    Neuroendocrinology, vol. 46, no. 2, pp. 137–142, 1987
  43. Interleukin-1 inhibits follicle stimulating hormone-induced differentiation in rat granulosa cells in vitro
    Biochemical and Biophysical Research Communications, vol. 149, no. 2, pp. 502–509, 1987
  44. Stimulation of ACTH release by human interleukin-1?, but not by interleukin-1?, in conscious, freely-moving rats
    Biochemical and Biophysical Research Communications, vol. 146, no. 3, pp. 1286–1290, 1987
  45. Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide
    Peptides, vol. 7, no. 6, pp. 1137–1145, 1986
  46. Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro
    Brain Research, vol. 380, no. 2, pp. 229–234, 1986
  47. Evidence for a Permanent Decline in Tuberoinfundibular Dopaminergic Neuronal Function after Chronic Estrogen Treatment Is Terminated in Fischer 344 Rats
    Neuroendocrinology, vol. 44, no. 2, pp. 211–216, 1986
  48. Reduced Tuberoinfundibular Dopaminergic Neuronal Function in Rats with in situ Prolactin-Secreting Pituitary Tumors
    Neuroendocrinology, vol. 38, no. 6, pp. 498–503, 1984
  49. Uptake and release of [3H]dopamine by the median eminence: Evidence for presynaptic dopaminergic receptors and for dopaminergic feedback inhibition
    Neuroscience, vol. 10, no. 3, pp. 821–830, 1983